Cargando…
Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)
For many years now, targeting deregulation within cancer cells’ metabolism has appeared as a promising strategy for the development of more specific and efficient cancer treatments. Recently, numerous reports highlighted the crucial role of the serine synthetic pathway, and particularly of the phosp...
Autores principales: | Spillier, Quentin, Ravez, Séverine, Unterlass, Judith, Corbet, Cyril, Degavre, Charline, Feron, Olivier, Frédérick, Raphaël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168936/ https://www.ncbi.nlm.nih.gov/pubmed/31979167 http://dx.doi.org/10.3390/ph13020020 |
Ejemplares similares
-
Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation
por: Spillier, Quentin, et al.
Publicado: (2019) -
Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments †
por: Spillier, Quentin, et al.
Publicado: (2021) -
Validating and enabling phosphoglycerate dehydrogenase (PHGDH) as a target for fragment-based drug discovery in PHGDH-amplified breast cancer
por: Unterlass, Judith E., et al.
Publicado: (2016) -
Structural insights into the enzymatic activity and potential substrate promiscuity of human 3-phosphoglycerate dehydrogenase (PHGDH)
por: Unterlass, Judith E., et al.
Publicado: (2017) -
Identification of Novel Natural Inhibitors to Human 3-Phosphoglycerate Dehydrogenase (PHGDH) for Cancer Treatment
por: Sadiqa, Ayesha, et al.
Publicado: (2022)